Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2026-02-24 @ 5:45 AM
Study NCT ID:
NCT03740334
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-21
First Post:
2018-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-08
First Submit QC Date:
None
Study First Post Date:
2018-11-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED